These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 33437218)

  • 1. QRS-T angle in patients with Hypertrophic Cardiomyopathy - A comparison with Cardiac Magnetic Resonance Imaging.
    Jensen CJ; Lambers M; Zadeh B; Wambach JM; Nassenstein K; Bruder O
    Int J Med Sci; 2021; 18(3):821-825. PubMed ID: 33437218
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of QRS-T angle and Late Gadolinium Enhancement in patients with a Clinical Suspicion of Myocarditis.
    Jensen CJ; Zadeh B; Wambach JM; Lambers M; Nassenstein K; Bruder O
    Int J Med Sci; 2021; 18(13):2905-2909. PubMed ID: 34220317
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlation of electrocardiographic changes and myocardial fibrosis in patients with hypertrophic cardiomyopathy detected by cardiac magnetic resonance imaging.
    Song BG; Yang HS; Hwang HK; Kang GH; Park YH; Chun WJ; Oh JH
    Clin Cardiol; 2013 Jan; 36(1):31-5. PubMed ID: 23070984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular late potentials and myocardial fibrosis in hypertrophic cardiomyopathy.
    Matsuki A; Kawasaki T; Kawamata H; Sakai C; Harimoto K; Kamitani T; Yamano M; Matoba S
    J Electrocardiol; 2020; 58():87-91. PubMed ID: 31790854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Klopotowski M; Kukula K; Malek LA; Spiewak M; Polanska-Skrzypczyk M; Jamiolkowski J; Dabrowski M; Baranowski R; Klisiewicz A; Kusmierczyk M; Jasinska A; Jarmus E; Kruk M; Ruzyllo W; Witkowski A; Chojnowska L
    J Cardiol; 2016 Jul; 68(1):49-56. PubMed ID: 26363820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy.
    Tezuka D; Kosuge H; Terashima M; Koyama N; Kishida T; Tada Y; Suzuki JI; Sasano T; Ashikaga T; Hirao K; Isobe M
    Heart Vessels; 2018 May; 33(5):513-520. PubMed ID: 29168014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QRS-T-angle in Patients with ST-Segment Elevation Myocardial Infarction (STEMI) - a Comparison with Cardiac Magnetic Resonance Imaging.
    Zadeh B; Wambach JM; Lambers M; Nassenstein K; Jensen CJ; Bruder O
    Int J Med Sci; 2020; 17(15):2264-2268. PubMed ID: 32922190
    [No Abstract]   [Full Text] [Related]  

  • 8. High ECG Risk-Scores Predict Late Gadolinium Enhancement on Magnetic Resonance Imaging in HCM in the Young.
    Österberg AW; Östman-Smith I; Jablonowski R; Carlsson M; Green H; Gunnarsson C; Liuba P; Fernlund E
    Pediatr Cardiol; 2021 Mar; 42(3):492-500. PubMed ID: 33515326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR.
    Moravsky G; Ofek E; Rakowski H; Butany J; Williams L; Ralph-Edwards A; Wintersperger BJ; Crean A
    JACC Cardiovasc Imaging; 2013 May; 6(5):587-96. PubMed ID: 23582356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal ischemic myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy.
    Zhi Y; Gui FD; Xue M; Long YT; Miao W; Yi Y; Gao LC; Bing F; Pan SY
    BMC Cardiovasc Disord; 2024 Apr; 24(1):203. PubMed ID: 38594610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of LGE-CMR in HCM: A Meta-Analysis.
    Weng Z; Yao J; Chan RH; He J; Yang X; Zhou Y; He Y
    JACC Cardiovasc Imaging; 2016 Dec; 9(12):1392-1402. PubMed ID: 27450876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notched QRS for the assessment of myocardial fibrosis in hypertrophic cardiomyopathy.
    Kawasaki T; Harimoto K; Honda S; Sato Y; Yamano M; Miki S; Kamitani T
    Circ J; 2015; 79(4):847-53. PubMed ID: 25739570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy.
    Ismail TF; Jabbour A; Gulati A; Mallorie A; Raza S; Cowling TE; Das B; Khwaja J; Alpendurada FD; Wage R; Roughton M; McKenna WJ; Moon JC; Varnava A; Shakespeare C; Cowie MR; Cook SA; Elliott P; O'Hanlon R; Pennell DJ; Prasad SK
    Heart; 2014 Dec; 100(23):1851-8. PubMed ID: 24966307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragmented QRS on electrocardiography as a predictor of myocardial scar in patients with hypertrophic cardiomyopathy.
    Ratheendran AC; Subramanian M; Bhanu DK; Prabhu MA; Kannan R; Natarajan KU; Saritha Sekhar S; Thachathodiyil R; Harikrishnan MS; Pai PG
    Acta Cardiol; 2020 Feb; 75(1):42-46. PubMed ID: 30602338
    [No Abstract]   [Full Text] [Related]  

  • 15. Electrocardiography based prediction of hypertrophy pattern and fibrosis amount in hypertrophic cardiomyopathy: comparative study with cardiac magnetic resonance imaging.
    Park CH; Chung H; Kim Y; Kim JY; Min PK; Lee KA; Yoon YW; Kim TH; Lee BK; Hong BK; Rim SJ; Kwon HM; Choi EY
    Int J Cardiovasc Imaging; 2018 Oct; 34(10):1619-1628. PubMed ID: 29728953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrocardiographic QRS Fragmentation as a Marker for Myocardial Fibrosis in Hypertrophic Cardiomyopathy.
    Konno T; Hayashi K; Fujino N; Oka R; Nomura A; Nagata Y; Hodatsu A; Sakata K; Furusho H; Takamura M; Nakamura H; Kawashiri MA; Yamagishi M
    J Cardiovasc Electrophysiol; 2015 Oct; 26(10):1081-7. PubMed ID: 26102305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitral annular plane systolic excursion is an easy tool for fibrosis detection by late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Doesch C; Sperb A; Sudarski S; Lossnitzer D; Rudic B; Tülümen E; Heggemann F; Schimpf R; Schoenberg SO; Borggrefe M; Papavassiliu T
    Arch Cardiovasc Dis; 2015; 108(6-7):356-66. PubMed ID: 25863428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy.
    Green JJ; Berger JS; Kramer CM; Salerno M
    JACC Cardiovasc Imaging; 2012 Apr; 5(4):370-7. PubMed ID: 22498326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial Fibrosis in Hypertrophic Cardiomyopathy: Volumetric Assessment of Late Enhancement Provided by Cardiac Computed Tomography.
    Langer C; Schaefer P; Lutz M; Eden M; Hohnhorst M; Harders H; Faber L; Jansen O; Both M; Frey N
    J Comput Assist Tomogr; 2015; 39(5):797-803. PubMed ID: 26125299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.